SCHEMBL28647032

SCHEMBL28647032

CN1CCN(C2CCCN(c3cnc(C(N)=O)cn3)C2)C1=O

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 19/20 0.59
▸ LCK P06239 18/20 0.59
▸ BTK Q06187 4/20 0.59
▸ EGFR P00533 11/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29931205 1.00 JAK3 (0.59) JAK3LCKBTKEGFR
SCHEMBL30160837 0.90 JAK3 (0.51) JAK3LCKBTKEGFR
SCHEMBL30161265 0.87 JAK3 (0.46) JAK3LCKBTKEGFR
SCHEMBL30160707 0.86 JAK3 (0.47) JAK3LCKBTKEGFR
SCHEMBL30161234 0.85 LCK (0.45) JAK3LCKBTKEGFR
SCHEMBL30160666 0.85 JAK3 (0.46) JAK3LCKBTKEGFR
SCHEMBL30160759 0.83 JAK3 (0.52) JAK3LCKBTKEGFR
SCHEMBL30160681 0.83 JAK3 (0.52) JAK3LCKBTKEGFR
SCHEMBL31039905 0.83 JAK3 (0.42) JAK3LCKBTKEGFR
SCHEMBL21946880 0.83 JAK3 (0.70) JAK3LCKBTKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115003304-A Bifunctional compounds for the degradation of BTK via the ubiquitin proteasome pathway 纽力克斯治疗公司 2022-09-02 — — CN disclosed
CN-113412259-A Bifunctional compounds for the degradation of BTK via the ubiquitin proteasome pathway 紐力克斯治疗公司 2021-09-17 — — CN disclosed
Send feedback